Literature DB >> 34371705

Accuracy of Dose Administered to Children Using Off-Labelled or Unlicensed Oral Dosage Forms.

Guillaume Binson1,2, Cécile Sanchez1, Karen Waton1, Adeline Chanat1, Massimo Di Maio3, Karine Beuzit1, Antoine Dupuis1,2.   

Abstract

The pediatric population suffers from a lack of age-appropriate medicines leading to unsafe situations when off-labelled or unlicensed drugs are used. Assessing the best option to administrate medicines when manipulations are required is essential in order to improve child care. This study aimed to compare the accuracy of the administered dose provided by three dosage forms and their techniques of administration. Different techniques of administration were assessed, covering three oral dosage forms (commercially available tablets, capsules, oral suspensions) using two APIs not available in a children-adapted dosage form. Techniques of administration were simulated and administered doses were determined using HPLC-UV. Means were compared to the target dose while distributions of doses were compared between each technique. For both APIs, mean administered doses obtained with capsules and tablets were significantly different from the target dose, whereas there was no statistical difference with oral suspensions. Distributions of doses showed significant difference between the three dosage forms. This study demonstrates that manipulations of solid oral dosage forms provide dramatic underdosing leading to unsafe situations. Compounded oral suspension is the best option to avoid underdosing and dose variation. This solution should be prioritized when age-appropriate commercial medicines are not available.

Entities:  

Keywords:  administration management; drug administration; off-labelled dosage forms; pediatric medicine; personalized medicine

Year:  2021        PMID: 34371705     DOI: 10.3390/pharmaceutics13071014

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  2 in total

1.  Development and evaluation of an assessment of the age-appropriateness/inappropriateness of formulations used in children.

Authors:  Jennifer C Duncan; Louise E Bracken; Anthony J Nunn; Matthew Peak; Mark A Turner
Journal:  Int J Clin Pharm       Date:  2022-10-08

2.  Compounded Nonsterile Preparations and FDA-Approved Commercially Available Liquid Products for Children: A North American Update.

Authors:  Richard H Parrish; Lisa D Ashworth; Raimar Löbenberg; Sandra Benavides; Jeffrey J Cies; Robert B MacArthur
Journal:  Pharmaceutics       Date:  2022-05-10       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.